Statistics
Publications
5
Citations
133
H-Index
5
Active since
2015
Emily S. Reardon is an author at National Cancer Institute specializing in oncology, molecular oncology, and medicine.
Publications per year
2015–2020
5
5
UHRF1 Is a Novel Druggable Epigenetic Target in Malignant Pleural Mesothelioma
Emily S. Reardon, Vivek Shukla, Sichuan Xi et al. · Journal of Thoracic Oncology · 2020 · 38 citations · Full text
Paul L. Feingold, Deborah R. Surman, Kate Brown et al. · Molecular Cancer Therapeutics · 2018 · 25 citations · Full text
Medicine, Cancer Biology, Oncology +17
Saïd C. Azoury, Joseph G. Crompton, David M. Straughan et al. · International Journal of Surgery Case Reports · 2015 · 10 citations · Full text
1–5 of 5